Glenmark Pharmaceuticals submits media release

09 Oct 2019 Evaluate

Glenmark Pharmaceuticals has informed about submission of media release titled ‘Glenmark Pharmaceuticals receives tentative ANDA approval for Dimethyl Fumarate Delayed?Release Capsules, 120 mg and 240 mg’. 

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1962.20 -3.55 (-0.18%)
08-Dec-2025 11:16 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.30
Dr. Reddys Lab 1276.15
Cipla 1511.75
Zydus Lifesciences 932.75
Lupin 2089.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×